PBE
ETF / Mutual Fund
Nyse American
Invesco Biotechnology & Genome Fund
$63.82
-$2.67 (-4.02%)
Price Chart
Overview
About PBE
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.
AUM
Volume
848.9K
Avg. Volume
625.3K
Expense Ratio
0.50%
Fund Information
Exchange
Nyse American
Sector
Risk & Correlation Analysis
Market Correlation
0.91
Moderate Correlation
Volatility
Low (0.18)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, PBE shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
AUM
Volume848.9K
Expense Ratio0.50%
Important Dates
Next Dividend
Next Earnings
Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025